임상 한눈에 보기

• 1건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• 모집 중 6건 · 완료/종료 5건
• Phase: PHASE2 · PHASE1, PHASE2 · PHASE3 · PHASE2, PHASE3
• Status: COMPLETED · RECRUITING · TERMINATED…
• 주요 endpoint: Factors associated with an increased rate of fatality among reports with an immune-related adverse event (irAE). · Factors associated with an increased reporting of main irAE types · Time to onset for each irAE type · Rate of relapse with treatment rechallenge · Incidence of Adverse Events (AEs)
• 등록 대상자(표본 합산): 약 149,332명
• 선택한 코호트 보고값: ORR 44.4%
• 핵심: The purpose of this study is to assess the safety profile of relatlimab plus nivolumab in combination with platinum doub…

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.